PZ Cormay (CRM) Stock Overview
Develops, manufactures, and sells diagnostic reagents and medical equipment in Poland. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
CRM Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
PZ Cormay S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | zł0.52 |
| 52 Week High | zł0.62 |
| 52 Week Low | zł0.35 |
| Beta | 0.93 |
| 1 Month Change | -1.14% |
| 3 Month Change | 0.78% |
| 1 Year Change | -7.14% |
| 3 Year Change | -41.90% |
| 5 Year Change | -58.57% |
| Change since IPO | -69.41% |
Recent News & Updates
Recent updates
Lacklustre Performance Is Driving PZ Cormay S.A.'s (WSE:CRM) Low P/S
Feb 19
Fewer Investors Than Expected Jumping On PZ Cormay S.A. (WSE:CRM)
Sep 08There's Been No Shortage Of Growth Recently For PZ Cormay's (WSE:CRM) Returns On Capital
Feb 27PZ Cormay (WSE:CRM) Is Experiencing Growth In Returns On Capital
Sep 15Shareholder Returns
| CRM | PL Medical Equipment | PL Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 5.1% |
| 1Y | -7.1% | -10.9% | 12.9% |
Return vs Industry: CRM exceeded the Polish Medical Equipment industry which returned -10.1% over the past year.
Return vs Market: CRM underperformed the Polish Market which returned 11.7% over the past year.
Price Volatility
| CRM volatility | |
|---|---|
| CRM Average Weekly Movement | 5.0% |
| Medical Equipment Industry Average Movement | 5.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in PL Market | 11.6% |
| 10% least volatile stocks in PL Market | 3.5% |
Stable Share Price: CRM has not had significant price volatility in the past 3 months compared to the Polish market.
Volatility Over Time: CRM's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 823 | Flavio Finotello | cormay.com |
PZ Cormay S.A. develops, manufactures, and sells diagnostic reagents and medical equipment in Poland. The company offers biochemistry, including analyzers, reagents, cleaning liquids, control materials, and calibators. It also offers general analytics, such as test strips, checks, and calibration strips.
PZ Cormay S.A. Fundamentals Summary
| CRM fundamental statistics | |
|---|---|
| Market cap | zł43.79m |
| Earnings (TTM) | -zł4.40m |
| Revenue (TTM) | zł92.02m |
Is CRM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CRM income statement (TTM) | |
|---|---|
| Revenue | zł92.02m |
| Cost of Revenue | zł58.56m |
| Gross Profit | zł33.46m |
| Other Expenses | zł37.87m |
| Earnings | -zł4.40m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 36.36% |
| Net Profit Margin | -4.79% |
| Debt/Equity Ratio | 0.4% |
How did CRM perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 16:57 |
| End of Day Share Price | 2025/06/30 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
PZ Cormay S.A. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pawel Puchalski | Santander Brokerage Poland |
| Lukasz Kosiarski | Santander Brokerage Poland |